PollNowData
Back to companies

ImmunityBio, Inc.

IBRXUSNASDAQPharmaceuticals & Healthcare

ImmunityBio, Inc.

Revenue
$113.3mn
YoY +668.3%
Operating income
-$256.0mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API